Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[PF-07256472]----[1] 276 💬
2ABSK061----[1] 276 💬
3Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily.----[1] 276 💬
4BGJ398 (also known as BBP-831)----[1] 276 💬
5BMN 111----[1] 276 💬
6BMN 111 administration via vial and syringe----[1] 276 💬
7BMN 333----[1] 276 💬
8C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker[1] Polyethylene glycol[3] Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--[1] 276 💬
9C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER[1] Polyethylene glycol[3] Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--[1] 276 💬
10Combination of Navepegritide and Lonapegsomatropin administered as two separate s.c. injections[2] Lonapegsomatropin,
Navepegritide		[2] Lonapegsomatropin ,
Navepegritide 💬 		[2] GHR,
NPR2 💬 		[10] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 276 💬
11Combination Product: BMN 111 administration via Injector Pen----[1] 276 💬
12INFIGRATINIB[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
13Infigratinib 0.016 mg/kg[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
14Infigratinib 0.032 mg/kg[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
15Infigratinib 0.064 mg/kg[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
16Infigratinib 0.128 mg/kg[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
17Infigratinib 0.25 mg/kg[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
18Infigratinib 0.25 mg/kg/day[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
19Infigratinib is provided as a single dose of minitablets for oral administration[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
20Infigratinib is provided as sprinkle capsules for daily oral administration[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
21Infigratinib phosphate[1] Infigratinib[2] Infigratinib ,
Infigratinib phosphate 💬 		[3] FGFR1,
FGFR2,
FGFR3 💬 		[22] Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, IgSF CAM signaling, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells, Thermogenesis 💬[1] 276 💬
22KK8398----[1] 276 💬
23Lonapegsomatropin[1] Lonapegsomatropin[1] Lonapegsomatropin 💬 [1] GHR 💬 [6] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 276 💬
24Modified recombinant human c-type----[1] 276 💬
25Modified recombinant human C-type natriuretic peptide----[1] 276 💬
26MODIFIED RHCNP----[1] 276 💬
27Natriuretic peptide----[1] 276 💬
28Navepegritide[1] Navepegritide[1] Navepegritide 💬 [1] NPR2 💬 [5] Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 276 💬
29Normal Saline----[20] 6, 13, 17, 22, 36, 46, 49, 60, 70, 71, 79, 94, 96, 97, 210, 211, 226, 276, 296, 299 💬
30Other: Recifercept[1] Recifercept[1] Recifercept 💬 [1] FGFR3 💬 [12] Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[1] 276 💬
31PF-07256472----[1] 276 💬
32Polyethylene glycol[1] Polyethylene glycol[3] Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--[8] 6, 50, 96, 97, 195, 235, 276, 299 💬
33Recifercept[1] Recifercept[1] Recifercept 💬 [1] FGFR3 💬 [12] Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[1] 276 💬
34Recifercept (proposed INN)[1] Recifercept[1] Recifercept 💬 [1] FGFR3 💬 [12] Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[1] 276 💬
35Recombinant human growth hormone----[4] 77, 193, 265, 276 💬
36SAR442501----[1] 276 💬
37Somatropin----[14] 3, 74, 75, 78, 97, 107, 113, 187, 193, 195, 222, 238, 274, 276 💬
38TA-46[1] Recifercept[1] Recifercept 💬 [1] FGFR3 💬 [12] Bladder cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬[1] 276 💬
39TBD----[5] 19, 86, 90, 276, 299 💬
40TransCon CNP----[1] 276 💬
41TransCon CNP 3.9 mg CNP-38/vial----[1] 276 💬
42TransCon CNP 3.9 mg CNP-38/vialProduct Code: TransCon CNPPharmaceutical Form: Powder and solvent for solution for injectionINN or Proposed INN: C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKERCAS Number: 2413551-27-4Current Sponsor code: TransCon CNPOther descriptive name: C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linkerConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 3.9-Pharmaceutical form of the placebo: Powder and solvent for solution for injectionRoute of administration of the placebo: Subcutaneous use[1] Polyethylene glycol[3] Polyethylene glycol 3350 ,
Macrogol 4000 ,
Macrogol 6000 💬 		--[1] 276 💬
43TYRA-300 0.125 mg/kg----[1] 276 💬
44TYRA-300 0.25 mg/kg----[1] 276 💬
45TYRA-300 0.375 mg/kg----[1] 276 💬
46TYRA-300 0.50 mg/kg----[1] 276 💬
47Vorsoritide----[1] 276 💬
48Vosoritide[1] Vosoritide[1] Vosoritide 💬 [1] NPR2 💬 [5] Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[3] 19, 195, 276 💬
49Vosoritide Injection [Voxzogo][1] Vosoritide[1] Vosoritide 💬 [1] NPR2 💬 [5] Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 19, 276 💬
50Voxzogo----[1] 276 💬